Friday, November 16, 2012
Intarcia Therapeutics Inc., of Hayward, Calif., completed two financings with total proceeds of $210 million consisting of $160 million from a preferred stock private placement and $50 million from a private debt placement.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.